Data / Form D filings / EPICYPHER, INC.
EPICYPHER, INC.: Form D filings
EPICYPHER, INC., a biotechnology company in Durham, NC, filed 4 Form D notices with the SEC between 2013 and 2024. The latest, on July 11, 2024, reports $3.3 million sold of a $3.3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6 DAVIS DRIVE, Durham, NC, 27709
- Phone
- (434) 996-8107
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1571691
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 11, 2024 | New notice | $3,300,000 | $3,300,000 | 1 | Jun 27, 2024 | sec.gov | |
| Jun 6, 2013 | New notice | $500,000 | $30,000 | $470,000 | 2 | May 24, 2013 | sec.gov |
| Apr 3, 2013 | Amendment | $60,000 | $35,300 | $24,700 | 2 | Mar 6, 2013 | sec.gov |
| Mar 20, 2013 | New notice | $60,000 | $25,300 | $34,700 | 1 | Mar 6, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Bedford | Director | |
| Or Gozani | Director | |
| Michael-Christopher Keogh | Director | |
| Andrew Barry | Director | |
| Joe McMahon | Director | |
| James Bone | Executive Officer, Director | |
| Brian Strahl | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Jul 8, 2024 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what EPICYPHER, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.